|
|
| Line 1: |
Line 1: |
| [[Image:1owd.gif|left|200px]] | | {{Seed}} |
| | [[Image:1owd.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1owd| PDB=1owd | SCENE= }} | | {{STRUCTURE_1owd| PDB=1owd | SCENE= }} |
|
| |
|
| '''Substituted 2-Naphthamidine inhibitors of urokinase'''
| | ===Substituted 2-Naphthamidine inhibitors of urokinase=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| The preparation and assessment of biological activity of 6-substituted 2-naphthamidine inhibitors of the serine protease urokinase plasminogen activator (uPA, or urokinase) is described. 2-Naphthamidine was chosen as a starting point based on synthetic considerations and on modeling of substituent vectors. Phenyl amides at the 6-position were found to improve binding; replacement of the amide with other two-atom linkers proved ineffective. The phenyl group itself is situated near the S1' subsite; substitutions off of the phenyl group accessed S1' and other distant binding regions. Three new points of interaction were defined and explored through ring substitution. A solvent-exposed salt bridge with the Asp60A carboxylate was formed using a 4-alkylamino group, improving affinity to K(i) = 40 nM. Inhibitors also accessed two hydrophobic regions. One interaction is characterized by a tight hydrophobic fit made with a small dimple largely defined by His57 and His99; a weaker, less specific interaction involves alkyl groups reaching into the broad prime-side protein binding region near Val41 and the Cys42-Cys58 disulfide, displacing water molecules and leading to small gains in activity. Many inhibitors accessed two of these three regions. Affinities range as low as K(i) = 6 nM, and many compounds had K(i) < 100 nM, while moderate to excellent selectivity was gained versus four of five members of a panel of relevant serine proteases. Also, some selectivity against trypsin was generated via the interaction with Asp60A. X-ray structures of many of these compounds were used to inform our inhibitor design and to increase our understanding of key interactions. In combination with our exploration of 8-substitution patterns, we have identified a number of novel binding interactions for uPA inhibitors. | | The line below this paragraph, {{ABSTRACT_PUBMED_14711304}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 14711304 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_14711304}} |
|
| |
|
| ==Disease== | | ==Disease== |
| Line 43: |
Line 47: |
| [[Category: Plasminogen activation]] | | [[Category: Plasminogen activation]] |
| [[Category: Serine protease]] | | [[Category: Serine protease]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 04:21:21 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 03:51:32 2008'' |